Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2207
2.890
Why?
Smoking
20
2019
1457
1.320
Why?
Bronchi
13
2018
250
1.280
Why?
Carcinoma in Situ
5
2019
44
1.160
Why?
Carcinoma, Squamous Cell
10
2018
577
0.810
Why?
Carcinogens
4
2012
105
0.800
Why?
Chemoprevention
3
2019
88
0.760
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
88
0.760
Why?
Lung
16
2020
3672
0.660
Why?
Carcinoma, Small Cell
7
2008
159
0.530
Why?
Bronchopulmonary Dysplasia
2
2019
330
0.510
Why?
Urethane
3
2012
41
0.510
Why?
Bronchoscopy
9
2019
245
0.490
Why?
Sputum
8
2019
290
0.490
Why?
Pulmonary Alveoli
4
2012
376
0.480
Why?
Iloprost
2
2012
46
0.480
Why?
Hyperplasia
7
2011
166
0.480
Why?
Precancerous Conditions
7
2020
156
0.460
Why?
Neprilysin
3
1998
47
0.440
Why?
Biomarkers, Tumor
7
2015
1048
0.430
Why?
Piperidines
2
2012
163
0.420
Why?
Antineoplastic Agents
4
2013
1893
0.420
Why?
Quinazolines
2
2012
241
0.410
Why?
Biopsy
11
2019
1056
0.410
Why?
DNA Copy Number Variations
1
2011
156
0.370
Why?
Genetic Markers
1
2011
325
0.360
Why?
Bombesin
5
1998
14
0.360
Why?
Amidohydrolases
3
1998
29
0.350
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
963
0.350
Why?
Neurosecretory Systems
4
2004
32
0.340
Why?
Isotretinoin
1
2009
22
0.330
Why?
Mass Screening
3
2008
1024
0.330
Why?
Ki-67 Antigen
3
2015
104
0.330
Why?
Tocopherols
1
2009
22
0.330
Why?
Vasodilator Agents
1
2011
308
0.330
Why?
ErbB Receptors
1
2012
557
0.320
Why?
Membrane Proteins
2
2008
1024
0.310
Why?
Neovascularization, Pathologic
6
2015
283
0.300
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
1098
0.290
Why?
Respiratory Mucosa
2
2008
258
0.280
Why?
Adenocarcinoma
6
2012
799
0.270
Why?
Hypoxia
1
2012
937
0.270
Why?
Middle Aged
28
2019
26999
0.240
Why?
Aged
25
2019
19251
0.240
Why?
Chromosomes, Human, Pair 3
4
2000
49
0.240
Why?
Chromosome Aberrations
4
2013
134
0.230
Why?
Carcinoma, Bronchogenic
2
2002
17
0.220
Why?
Humans
53
2020
115587
0.210
Why?
Tomography, Spiral Computed
1
2002
24
0.210
Why?
Female
33
2019
59913
0.210
Why?
Sensitivity and Specificity
10
2010
1718
0.200
Why?
Double-Blind Method
2
2019
1660
0.190
Why?
Smokers
2
2019
147
0.190
Why?
Lung Diseases
5
2015
710
0.190
Why?
Small Cell Lung Carcinoma
2
2012
77
0.190
Why?
Placebos
2
2019
198
0.190
Why?
Male
30
2019
55949
0.190
Why?
Tomography, X-Ray Computed
2
2020
2392
0.190
Why?
Tumor Cells, Cultured
6
1998
850
0.170
Why?
Neuropeptides
4
1998
65
0.170
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
106
0.170
Why?
Remission Induction
1
2019
240
0.160
Why?
Peptides
3
1996
864
0.160
Why?
In Situ Hybridization, Fluorescence
6
2010
310
0.150
Why?
Blotting, Western
4
2012
1153
0.150
Why?
Lung Diseases, Obstructive
1
1997
40
0.150
Why?
Genes, p53
1
1997
62
0.150
Why?
Antibodies, Monoclonal
3
2010
1265
0.150
Why?
Proteomics
2
2015
859
0.140
Why?
Point Mutation
1
1997
217
0.140
Why?
Immunohistochemistry
8
2015
1642
0.140
Why?
Mice
10
2012
15052
0.130
Why?
Radiation Injuries, Experimental
1
1996
25
0.130
Why?
Animals
13
2013
32102
0.130
Why?
Bradykinin
1
1996
46
0.130
Why?
Endopeptidases
1
1996
72
0.130
Why?
Chromosomal Instability
2
2013
19
0.130
Why?
Smoking Cessation
1
2019
377
0.130
Why?
Hyperoxia
1
1996
97
0.120
Why?
Risk Factors
5
2019
8697
0.120
Why?
Multiple Pulmonary Nodules
1
2015
27
0.120
Why?
Aged, 80 and over
8
2015
6417
0.120
Why?
Gene Expression
3
1998
1435
0.120
Why?
Mice, Transgenic
5
2009
1970
0.120
Why?
Antigens
1
1996
323
0.120
Why?
Methylcholanthrene
2
2012
18
0.120
Why?
Mutation
4
2000
3364
0.120
Why?
Butylated Hydroxytoluene
2
2012
32
0.120
Why?
Algorithms
3
2020
1490
0.120
Why?
Stem Cells
1
2018
546
0.110
Why?
Microarray Analysis
1
2013
119
0.110
Why?
Epithelium
4
2018
297
0.110
Why?
Intramolecular Oxidoreductases
2
2004
56
0.110
Why?
Biological Products
1
1996
172
0.110
Why?
Epithelial Cells
3
2007
961
0.110
Why?
Carcinoma, Large Cell
1
2012
14
0.110
Why?
Risk
5
2012
819
0.110
Why?
Cytochrome P-450 Enzyme System
2
2004
108
0.110
Why?
Case-Control Studies
8
2012
3022
0.100
Why?
Receptors, Bombesin
1
2012
4
0.100
Why?
Bronchoalveolar Lavage Fluid
3
2002
608
0.100
Why?
Volatile Organic Compounds
1
2012
45
0.100
Why?
Immunoenzyme Techniques
1
2012
193
0.100
Why?
Cell Division
4
2000
759
0.100
Why?
Veterans
1
2002
1233
0.100
Why?
Sleep Apnea Syndromes
1
2012
74
0.100
Why?
Proto-Oncogene Proteins c-myc
1
2012
114
0.100
Why?
Dose-Response Relationship, Drug
2
2010
1870
0.100
Why?
Chromosomes, Human, Pair 15
1
2011
53
0.090
Why?
Eosinophilic Granuloma
1
1990
3
0.090
Why?
Epithelial-Mesenchymal Transition
1
2012
167
0.090
Why?
Adult
16
2018
30718
0.090
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
225
0.090
Why?
Antioxidants
2
2012
533
0.090
Why?
Disease Progression
5
2018
2418
0.090
Why?
Calcium
1
1996
1103
0.090
Why?
Genome-Wide Association Study
2
2013
1217
0.090
Why?
Predictive Value of Tests
4
2009
1805
0.090
Why?
Cell Line
5
2013
2651
0.090
Why?
Proteins
1
1996
920
0.090
Why?
Plants, Toxic
1
1989
28
0.090
Why?
Cell Proliferation
2
2018
2194
0.090
Why?
Somatomedins
1
2009
29
0.090
Why?
Intracellular Signaling Peptides and Proteins
2
2011
388
0.080
Why?
Chromosome Deletion
1
1989
95
0.080
Why?
Bronchial Neoplasms
1
2009
14
0.080
Why?
Neoplasms, Glandular and Epithelial
1
2009
39
0.080
Why?
Neoplasm Invasiveness
4
2015
445
0.080
Why?
GPI-Linked Proteins
1
2008
54
0.080
Why?
Respiratory System
1
1989
141
0.080
Why?
Airway Obstruction
3
2009
168
0.080
Why?
Fluorescence
3
2009
154
0.080
Why?
Inflammation
1
2018
2499
0.070
Why?
Alkaline Phosphatase
1
2008
144
0.070
Why?
Polymorphism, Genetic
1
2011
621
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Fibroblasts
3
1998
839
0.070
Why?
Molecular Targeted Therapy
1
2010
348
0.070
Why?
Isoenzymes
1
2008
285
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
228
0.070
Why?
Cell Transformation, Neoplastic
1
2009
314
0.070
Why?
Pulmonary Surfactants
2
1999
101
0.070
Why?
Early Detection of Cancer
1
2010
340
0.070
Why?
Exons
2
1998
300
0.070
Why?
Molecular Sequence Data
5
1998
2790
0.070
Why?
Follow-Up Studies
2
2015
4440
0.070
Why?
MicroRNAs
1
2012
607
0.070
Why?
Polymorphism, Single Nucleotide
1
2013
1918
0.070
Why?
Biomarkers
3
2010
3466
0.070
Why?
ROC Curve
3
2015
451
0.070
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
795
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
374
0.060
Why?
Recombinant Proteins
3
1998
1243
0.060
Why?
RNA, Messenger
3
1998
2574
0.060
Why?
Polymerase Chain Reaction
3
1998
1000
0.060
Why?
Protein Kinase Inhibitors
1
2010
790
0.060
Why?
Cytokines
1
2012
1853
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
27
0.060
Why?
Acromegaly
1
2004
12
0.060
Why?
Rats
4
2004
5034
0.060
Why?
Neoplasm Recurrence, Local
1
2009
863
0.060
Why?
Adrenocorticotropic Hormone
1
2004
148
0.060
Why?
Cross-Sectional Studies
2
2018
4435
0.050
Why?
Smoke
1
2004
133
0.050
Why?
Base Sequence
3
1998
2114
0.050
Why?
Solitary Pulmonary Nodule
1
2002
25
0.050
Why?
Metaplasia
2
2018
54
0.050
Why?
Sex Factors
1
2007
1736
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
503
0.050
Why?
Pulmonary Fibrosis
2
1998
330
0.050
Why?
Radiation Dosage
1
2002
139
0.050
Why?
Hospitals, Veterans
1
2002
245
0.050
Why?
Reproducibility of Results
1
2008
2800
0.050
Why?
Cohort Studies
4
2015
4944
0.040
Why?
Gene Expression Regulation
1
1989
2353
0.040
Why?
Feasibility Studies
1
2002
741
0.040
Why?
Amino Acid Sequence
3
1994
2000
0.040
Why?
Signal Transduction
3
1998
4541
0.040
Why?
Gastrin-Releasing Peptide
2
1996
6
0.040
Why?
Light
1
2001
337
0.040
Why?
Autocrine Communication
1
1998
43
0.040
Why?
gamma Catenin
1
2018
17
0.040
Why?
Desmoglein 3
1
2018
17
0.040
Why?
Loss of Heterozygosity
2
2013
41
0.040
Why?
Gene Expression Profiling
1
2005
1536
0.040
Why?
DNA Primers
2
1998
514
0.040
Why?
Paracrine Communication
1
1998
56
0.040
Why?
Up-Regulation
2
2005
820
0.040
Why?
Bronchial Diseases
1
2018
38
0.040
Why?
Neoplasm Transplantation
1
1998
235
0.040
Why?
United States
2
2011
12295
0.040
Why?
Cell Cycle Checkpoints
1
2018
84
0.040
Why?
Time
1
2018
72
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
36
0.040
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
10
0.040
Why?
Polymorphism, Single-Stranded Conformational
1
1997
27
0.040
Why?
Genes, Tumor Suppressor
1
1998
78
0.040
Why?
Likelihood Functions
1
1998
128
0.040
Why?
Neoplasm Staging
2
2012
1178
0.040
Why?
Alveolitis, Extrinsic Allergic
1
1998
92
0.040
Why?
Polymorphism, Restriction Fragment Length
1
1997
65
0.040
Why?
DNA, Complementary
1
1998
258
0.040
Why?
Treatment Outcome
1
2011
9159
0.040
Why?
Gene Expression Regulation, Enzymologic
1
1998
274
0.040
Why?
Codon
1
1997
86
0.040
Why?
Introns
1
1998
226
0.040
Why?
Membrane Glycoproteins
1
1999
431
0.040
Why?
Mice, Nude
1
1998
639
0.040
Why?
Incidence
3
2010
2335
0.040
Why?
Machine Learning
1
2020
321
0.030
Why?
Immunoassay
2
1998
97
0.030
Why?
Enzyme Activation
1
1998
793
0.030
Why?
RNA, Neoplasm
1
1996
80
0.030
Why?
Image Processing, Computer-Assisted
1
2020
691
0.030
Why?
Mesothelioma
1
1996
31
0.030
Why?
Glycopeptides
1
1996
43
0.030
Why?
Antigens, CD
2
1998
442
0.030
Why?
Databases, Factual
1
2020
1138
0.030
Why?
Sequence Analysis, DNA
1
1998
732
0.030
Why?
Proto-Oncogene Proteins
1
2018
609
0.030
Why?
Cell Cycle Proteins
1
2018
553
0.030
Why?
Myelin Sheath
1
1996
145
0.030
Why?
Prospective Studies
3
2012
6264
0.030
Why?
Receptors, Peptide
1
1994
21
0.030
Why?
Rh-Hr Blood-Group System
1
1994
10
0.030
Why?
Liver Neoplasms
1
1998
521
0.030
Why?
Neoplasm Metastasis
1
1996
526
0.030
Why?
Erythrocyte Membrane
1
1994
50
0.030
Why?
Blotting, Southern
1
1993
66
0.030
Why?
Blotting, Northern
1
1993
194
0.030
Why?
Endoscopy
1
2015
247
0.030
Why?
Cells, Cultured
2
2007
3914
0.030
Why?
DNA, Neoplasm
1
1993
157
0.030
Why?
Colorado
1
2002
4113
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
1147
0.030
Why?
Solid Phase Microextraction
1
2012
6
0.030
Why?
Dinoprostone
2
2004
186
0.030
Why?
Fluorescent Antibody Technique
1
1993
398
0.030
Why?
Enzyme Inhibitors
1
1996
757
0.030
Why?
Breath Tests
1
2012
83
0.030
Why?
Gas Chromatography-Mass Spectrometry
1
2012
125
0.030
Why?
Cloning, Molecular
1
1993
523
0.030
Why?
Iceland
1
2011
6
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
12
0.020
Why?
Respiratory Tract Diseases
1
1992
142
0.020
Why?
Spain
1
2011
34
0.020
Why?
Netherlands
1
2011
64
0.020
Why?
Rats, Sprague-Dawley
1
1996
2262
0.020
Why?
Cattle
1
1993
935
0.020
Why?
Administration, Oral
1
2012
734
0.020
Why?
Severity of Illness Index
1
2018
2578
0.020
Why?
Prognosis
2
2012
3339
0.020
Why?
Meta-Analysis as Topic
1
2011
161
0.020
Why?
Carrier Proteins
1
1994
701
0.020
Why?
Flow Cytometry
1
1993
1083
0.020
Why?
Receptor, IGF Type 1
1
2009
58
0.020
Why?
Area Under Curve
1
2010
278
0.020
Why?
Cystic Fibrosis
1
1998
957
0.020
Why?
International Agencies
1
2009
29
0.020
Why?
Erythrocytes
1
1994
589
0.020
Why?
Pilot Projects
1
2012
1377
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
477
0.020
Why?
Mass Spectrometry
1
2010
645
0.020
Why?
Genome, Human
1
2009
352
0.020
Why?
Models, Statistical
1
2010
606
0.020
Why?
Disease Models, Animal
1
1996
3580
0.020
Why?
Amino Acids
1
1989
454
0.020
Why?
Genotype
1
2011
1786
0.020
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
104
0.020
Why?
Genomics
1
2009
645
0.010
Why?
Epoprostenol
1
2004
133
0.010
Why?
Bronchiolitis
1
2004
83
0.010
Why?
Autoantibodies
1
2010
1360
0.010
Why?
Pituitary Neoplasms
1
2004
157
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
930
0.010
Why?
Fruit
1
2003
127
0.010
Why?
Vegetables
1
2003
133
0.010
Why?
Genetic Predisposition to Disease
1
2011
2125
0.010
Why?
Respiratory Function Tests
1
2004
535
0.010
Why?
Adenoma
1
2004
187
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
746
0.010
Why?
Weight Gain
1
2004
453
0.010
Why?
Regression Analysis
1
2003
959
0.010
Why?
Single-Blind Method
1
2001
255
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
57
0.010
Why?
Carcinoma
1
2001
200
0.010
Why?
RNA
1
2005
819
0.010
Why?
Retrospective Studies
1
2015
12608
0.010
Why?
Bronchoscopes
1
1998
4
0.010
Why?
Endoglin
1
1998
20
0.010
Why?
Random Allocation
1
1998
337
0.010
Why?
Reference Values
1
1998
744
0.010
Why?
Genetic Linkage
1
1998
297
0.010
Why?
Longitudinal Studies
1
2003
2416
0.010
Why?
Comorbidity
1
2001
1473
0.010
Why?
Diet
1
2003
1072
0.010
Why?
Tumor Suppressor Protein p53
1
2000
449
0.010
Why?
Linear Models
1
1998
776
0.010
Why?
Receptors, Cell Surface
1
1998
356
0.010
Why?
Young Adult
1
2011
10470
0.010
Why?
Analysis of Variance
1
1998
1227
0.010
Why?
Alleles
1
1998
794
0.010
Why?
Infant, Premature
1
1998
477
0.010
Why?
Risk Assessment
1
2004
2987
0.010
Why?
CD47 Antigen
1
1994
21
0.010
Why?
Chromatography, Affinity
1
1994
83
0.010
Why?
Endothelium, Vascular
1
2000
845
0.010
Why?
Moths
1
1994
34
0.010
Why?
Genes
1
1994
224
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
312
0.010
Why?
Cytoplasm
1
1994
255
0.010
Why?
Chromosome Mapping
1
1994
489
0.010
Why?
Adolescent
1
2011
17889
0.010
Why?
Carcinoid Tumor
1
1992
25
0.010
Why?
Lymphocytes
1
1994
344
0.010
Why?
Transfection
1
1994
866
0.010
Why?
Mice, Inbred BALB C
1
1994
1168
0.010
Why?
Dyspnea
1
1992
223
0.010
Why?
Binding Sites
1
1994
1177
0.010
Why?
Fibrosis
1
1992
457
0.010
Why?
Phenotype
1
1998
2829
0.010
Why?
Aging
1
1998
1631
0.000
Why?
Infant, Newborn
1
1998
5077
0.000
Why?
Infant
1
1998
7979
0.000
Why?
Child, Preschool
1
1998
9133
0.000
Why?
Child
1
1998
18488
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)